Skip to main content
. 2021 Jan 8;11:234. doi: 10.1038/s41598-020-79918-3

Figure 4.

Figure 4

Docked poses of Mpro enzyme with the proposed inhibitors. 2D plots and binding interactions of Mpro enzyme with compounds (A) Daunorubicin, (B) ABBV-744 and (C) Onalespib. Lower panels are representing the surface view of conserved substrate-binding pocket of Mpro in complexed with Daunorubicin, ABBV-744 and Onalespib, respectively (left to right).